REMIBRUTINIB FOR USE IN THE TREATMENT OF HIDRADENITIS SUPPURATIVA

The present disclosure relates to methods for treating and/or preventing Hidradenitis Suppurativa in a subject having such disease or condition comprising administering a therapeutically effective dose of LOU064. Also disclosed are medicaments, dosing regimens, pharmaceutical compositions, combinati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BIETH, Bruno, JUHNKE, Michael, GRAHAM, Gordon, ZIERER, Jonas Benjamin, LOESCHE, Christian, CENNI, Bruno, RAPP, Karin, SIN, Kim-Hien, BHATTACHARYA, Souvik
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BIETH, Bruno
JUHNKE, Michael
GRAHAM, Gordon
ZIERER, Jonas Benjamin
LOESCHE, Christian
CENNI, Bruno
RAPP, Karin
SIN, Kim-Hien
BHATTACHARYA, Souvik
description The present disclosure relates to methods for treating and/or preventing Hidradenitis Suppurativa in a subject having such disease or condition comprising administering a therapeutically effective dose of LOU064. Also disclosed are medicaments, dosing regimens, pharmaceutical compositions, combinations, dosage forms, and kits for use in the disclosed uses and methods. La présente invention concerne des méthodes de traitement et/ou de prévention de l'hidradénite suppurée chez un sujet atteint d'une telle maladie ou affection, comprenant l'administration d'une dose thérapeutiquement efficace de LOU064. L'invention concerne également des médicaments, des schémas posologiques, des compositions pharmaceutiques, des combinaisons, des formes posologiques et des kits destinés à être employés dans les utilisations et les procédés de l'invention.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023161887A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023161887A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023161887A13</originalsourceid><addsrcrecordid>eNqNyrEKwjAQANAsDqL-w4GzYFrQrld7ITc0KZeLjqVInEQL9f9x8QOc3vLWBoV6biUrB27BRYGcCDiAegIVQu0pKEQHnjvBjgIrJ0h5GLKg8hW3ZvWYnkvZ_dyYvSO9-EOZ32NZ5uleXuUz3mJ1rGp7sk1zRlv_t76ZjCwh</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>REMIBRUTINIB FOR USE IN THE TREATMENT OF HIDRADENITIS SUPPURATIVA</title><source>esp@cenet</source><creator>BIETH, Bruno ; JUHNKE, Michael ; GRAHAM, Gordon ; ZIERER, Jonas Benjamin ; LOESCHE, Christian ; CENNI, Bruno ; RAPP, Karin ; SIN, Kim-Hien ; BHATTACHARYA, Souvik</creator><creatorcontrib>BIETH, Bruno ; JUHNKE, Michael ; GRAHAM, Gordon ; ZIERER, Jonas Benjamin ; LOESCHE, Christian ; CENNI, Bruno ; RAPP, Karin ; SIN, Kim-Hien ; BHATTACHARYA, Souvik</creatorcontrib><description>The present disclosure relates to methods for treating and/or preventing Hidradenitis Suppurativa in a subject having such disease or condition comprising administering a therapeutically effective dose of LOU064. Also disclosed are medicaments, dosing regimens, pharmaceutical compositions, combinations, dosage forms, and kits for use in the disclosed uses and methods. La présente invention concerne des méthodes de traitement et/ou de prévention de l'hidradénite suppurée chez un sujet atteint d'une telle maladie ou affection, comprenant l'administration d'une dose thérapeutiquement efficace de LOU064. L'invention concerne également des médicaments, des schémas posologiques, des compositions pharmaceutiques, des combinaisons, des formes posologiques et des kits destinés à être employés dans les utilisations et les procédés de l'invention.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230831&amp;DB=EPODOC&amp;CC=WO&amp;NR=2023161887A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230831&amp;DB=EPODOC&amp;CC=WO&amp;NR=2023161887A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BIETH, Bruno</creatorcontrib><creatorcontrib>JUHNKE, Michael</creatorcontrib><creatorcontrib>GRAHAM, Gordon</creatorcontrib><creatorcontrib>ZIERER, Jonas Benjamin</creatorcontrib><creatorcontrib>LOESCHE, Christian</creatorcontrib><creatorcontrib>CENNI, Bruno</creatorcontrib><creatorcontrib>RAPP, Karin</creatorcontrib><creatorcontrib>SIN, Kim-Hien</creatorcontrib><creatorcontrib>BHATTACHARYA, Souvik</creatorcontrib><title>REMIBRUTINIB FOR USE IN THE TREATMENT OF HIDRADENITIS SUPPURATIVA</title><description>The present disclosure relates to methods for treating and/or preventing Hidradenitis Suppurativa in a subject having such disease or condition comprising administering a therapeutically effective dose of LOU064. Also disclosed are medicaments, dosing regimens, pharmaceutical compositions, combinations, dosage forms, and kits for use in the disclosed uses and methods. La présente invention concerne des méthodes de traitement et/ou de prévention de l'hidradénite suppurée chez un sujet atteint d'une telle maladie ou affection, comprenant l'administration d'une dose thérapeutiquement efficace de LOU064. L'invention concerne également des médicaments, des schémas posologiques, des compositions pharmaceutiques, des combinaisons, des formes posologiques et des kits destinés à être employés dans les utilisations et les procédés de l'invention.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQANAsDqL-w4GzYFrQrld7ITc0KZeLjqVInEQL9f9x8QOc3vLWBoV6biUrB27BRYGcCDiAegIVQu0pKEQHnjvBjgIrJ0h5GLKg8hW3ZvWYnkvZ_dyYvSO9-EOZ32NZ5uleXuUz3mJ1rGp7sk1zRlv_t76ZjCwh</recordid><startdate>20230831</startdate><enddate>20230831</enddate><creator>BIETH, Bruno</creator><creator>JUHNKE, Michael</creator><creator>GRAHAM, Gordon</creator><creator>ZIERER, Jonas Benjamin</creator><creator>LOESCHE, Christian</creator><creator>CENNI, Bruno</creator><creator>RAPP, Karin</creator><creator>SIN, Kim-Hien</creator><creator>BHATTACHARYA, Souvik</creator><scope>EVB</scope></search><sort><creationdate>20230831</creationdate><title>REMIBRUTINIB FOR USE IN THE TREATMENT OF HIDRADENITIS SUPPURATIVA</title><author>BIETH, Bruno ; JUHNKE, Michael ; GRAHAM, Gordon ; ZIERER, Jonas Benjamin ; LOESCHE, Christian ; CENNI, Bruno ; RAPP, Karin ; SIN, Kim-Hien ; BHATTACHARYA, Souvik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023161887A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BIETH, Bruno</creatorcontrib><creatorcontrib>JUHNKE, Michael</creatorcontrib><creatorcontrib>GRAHAM, Gordon</creatorcontrib><creatorcontrib>ZIERER, Jonas Benjamin</creatorcontrib><creatorcontrib>LOESCHE, Christian</creatorcontrib><creatorcontrib>CENNI, Bruno</creatorcontrib><creatorcontrib>RAPP, Karin</creatorcontrib><creatorcontrib>SIN, Kim-Hien</creatorcontrib><creatorcontrib>BHATTACHARYA, Souvik</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BIETH, Bruno</au><au>JUHNKE, Michael</au><au>GRAHAM, Gordon</au><au>ZIERER, Jonas Benjamin</au><au>LOESCHE, Christian</au><au>CENNI, Bruno</au><au>RAPP, Karin</au><au>SIN, Kim-Hien</au><au>BHATTACHARYA, Souvik</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>REMIBRUTINIB FOR USE IN THE TREATMENT OF HIDRADENITIS SUPPURATIVA</title><date>2023-08-31</date><risdate>2023</risdate><abstract>The present disclosure relates to methods for treating and/or preventing Hidradenitis Suppurativa in a subject having such disease or condition comprising administering a therapeutically effective dose of LOU064. Also disclosed are medicaments, dosing regimens, pharmaceutical compositions, combinations, dosage forms, and kits for use in the disclosed uses and methods. La présente invention concerne des méthodes de traitement et/ou de prévention de l'hidradénite suppurée chez un sujet atteint d'une telle maladie ou affection, comprenant l'administration d'une dose thérapeutiquement efficace de LOU064. L'invention concerne également des médicaments, des schémas posologiques, des compositions pharmaceutiques, des combinaisons, des formes posologiques et des kits destinés à être employés dans les utilisations et les procédés de l'invention.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2023161887A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title REMIBRUTINIB FOR USE IN THE TREATMENT OF HIDRADENITIS SUPPURATIVA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T12%3A09%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BIETH,%20Bruno&rft.date=2023-08-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023161887A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true